Czech National Bank Has $91.31 Million Stock Holdings in Procter & Gamble Company (The) $PG

Key Points

• The Czech National Bank increased its stake in Procter & Gamble by 6.4%, holding 573,089 shares valued at approximately $91.31 million.
• Procter & Gamble reported a net margin of 18.95% in its latest earnings report, with a revenue of $20.89 billion, exceeding analysts' expectations.
• The company declared a quarterly dividend of $1.0568 per share, representing an annualized yield of 2.7% with a payout ratio of 64.98%.

Czech National Bank boosted its holdings in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 6.4% in the second quarter, according to its most recent filing with the SEC. The firm owned 573,089 shares of the company's stock after acquiring an additional 34,513 shares during the period. Procter & Gamble accounts for 0.7% of Czech National Bank's portfolio, making the stock its 19th largest position. Czech National Bank's holdings in Procter & Gamble were worth $91,305,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of PG. Nuveen LLC acquired a new stake in Procter & Gamble during the 1st quarter worth $1,954,941,000. GAMMA Investing LLC grew its holdings in Procter & Gamble by 20,758.5% during the 1st quarter. GAMMA Investing LLC now owns 7,951,456 shares of the company's stock worth $1,355,087,000 after acquiring an additional 7,913,335 shares during the period. Price T Rowe Associates Inc. MD grew its holdings in shares of Procter & Gamble by 13.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company's stock valued at $3,660,737,000 after buying an additional 2,466,308 shares during the period. Invesco Ltd. increased its position in shares of Procter & Gamble by 19.8% in the 1st quarter. Invesco Ltd. now owns 13,493,604 shares of the company's stock valued at $2,299,580,000 after buying an additional 2,228,151 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in shares of Procter & Gamble by 15.8% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 16,274,563 shares of the company's stock valued at $2,728,430,000 after buying an additional 2,224,912 shares in the last quarter. Institutional investors and hedge funds own 65.77% of the company's stock.

Insider Activity at Procter & Gamble

In other news, CEO Gary A. Coombe sold 10,194 shares of the stock in a transaction dated Thursday, August 21st. The shares were sold at an average price of $158.16, for a total transaction of $1,612,283.04. Following the completion of the transaction, the chief executive officer directly owned 34,978 shares in the company, valued at $5,532,120.48. This represents a 22.57% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Marc S. Pritchard sold 9,849 shares of the stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $1,548,952.23. Following the transaction, the insider owned 182,422 shares of the company's stock, valued at approximately $28,689,507.94. This represents a 5.12% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 120,181 shares of company stock worth $18,918,012. Corporate insiders own 0.20% of the company's stock.

Procter & Gamble Price Performance

Shares of NYSE PG opened at $156.93 on Tuesday. The firm has a market cap of $367.30 billion, a PE ratio of 24.11, a PEG ratio of 4.17 and a beta of 0.36. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49. Procter & Gamble Company has a 1-year low of $149.91 and a 1-year high of $180.43. The company has a fifty day moving average price of $156.14 and a 200 day moving average price of $161.65.

Procter & Gamble (NYSE:PG - Get Free Report) last announced its earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, topping analysts' consensus estimates of $1.42 by $0.06. The firm had revenue of $20.89 billion during the quarter, compared to analyst estimates of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The company's revenue for the quarter was up 1.7% compared to the same quarter last year. During the same period in the prior year, the business earned $1.40 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Research analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 18th were paid a dividend of $1.0568 per share. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.7%. The ex-dividend date was Friday, July 18th. Procter & Gamble's dividend payout ratio is currently 64.98%.

Wall Street Analyst Weigh In

PG has been the subject of a number of recent analyst reports. UBS Group set a $180.00 price objective on shares of Procter & Gamble and gave the company a "buy" rating in a research report on Wednesday, July 30th. Barclays set a $164.00 price objective on shares of Procter & Gamble and gave the company an "equal weight" rating in a research report on Thursday, July 31st. JPMorgan Chase & Co. restated a "neutral" rating and issued a $170.00 price objective (down previously from $178.00) on shares of Procter & Gamble in a research report on Friday, July 25th. Wells Fargo & Company lowered their price objective on shares of Procter & Gamble from $175.00 to $173.00 and set an "overweight" rating for the company in a research report on Wednesday, July 30th. Finally, BNP Paribas restated an "outperform" rating and issued a $177.00 price objective on shares of Procter & Gamble in a research report on Friday, August 15th. One research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and seven have given a Hold rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $175.12.

Procter & Gamble Company Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.